Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Treatment and Rehabilitation - Medical Products	181.72M	-	-						99.57M	61.78M
Treatment and Rehabilitation - Home Products	56.20M	-	-						3.37M	2.41M
in Vitro Diagnostics - Inspection Equipment	249.37M	-	-						69.66M	61.04M
in Vitro Diagnostics - Test Reagents	528.40M	-	-						76.41M	47.55M
Unallocated Others	22.14M	-	-						1.83M	1.76M
Total	1.04B	-	-						250.83M	174.54M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	601.96M	-	-						233.71M	163.05M
Foreign	435.87M	-	-						15.29M	9.73M
Total	1.04B	-	-						249.00M	172.77M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error